Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors
Clinical trial NCT05714748 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05714748
- Sponsor
- West China Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-08
- Primary completion
- 2025-05-31
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.